Abbott is testing its rapid coronavirus test on asymptomatic people in hopes of expanding FDA authorization

"We are running our clinical trial and we'll eventually have data to be able to support that," Abbott Laboratories CEO Robert Ford told CNBC.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.